肯尼亚住院患者中产超广谱头孢菌素耐药和碳青霉烯耐药肠杆菌目定植的危险因素:社区与医院抗生素耐药(ARCH)研究
在肯尼亚1家城市和3家农村医院开展的横断面研究,纳入840例住院患者,采集粪便检测超广谱头孢菌素耐药肠杆菌目(ESCrE)和碳青霉烯耐药肠杆菌目(CRE)定植,用LASSO回归分析危险因素。CRE定植与头孢曲松使用及抗生素使用天数相关,ESCrE定植与住院时间和侵入性医疗器械相关,可能反映医院内传播。
要点
- 76%的840例受试者在入组前14天内使用过至少1种抗生素,主要为头孢曲松(46%)。
- CRE定植 odds 随头孢曲松使用(OR 2.23)和每增加一天抗生素使用(OR 1.08)而升高。
- ESCrE定植 odds 随住院≥3天(OR 2.32)、插管(OR 1.73)和HIV感染(OR 1.70)而升高。
核心结论
- CRE定植与头孢曲松使用和抗生素使用时长强相关,ESCrE定植 odds 随医院环境暴露和侵入性医疗器械使用而升高,可能反映医院内传播。
- 这些数据提示医院可通过感染预防控制和抗生素管理项目干预定植。
研究设计与样本
- 2019年1月至2020年3月在肯尼亚1家城市和3家农村医院开展的横断面研究。
- 随机纳入住院患者,采集粪便样本检测ESCrE和CRE,使用Vitek2仪器确认分离株和药敏试验,采用LASSO回归模型识别定植危险因素。
- 共纳入840例参与者。
主要发现
- 840例参与者中76%在入组前14天内接受过至少1种抗生素,主要为头孢曲松(46%)、甲硝唑(28%)或苄青霉素-庆大霉素(23%)。
- 在包含头孢曲松给药的LASSO模型中,ESCrE定植 odds 在住院≥3天患者中更高(OR 2.32,95%CI 1.6-3.37,P < .001),插管患者更高(OR 1.73,95%CI 1.03-2.91,P = .009),HIV感染者更高(OR 1.70,95%CI 1.03-2.8,P = .029)。
- CRE定植 odds 在接受头孢曲松的患者中更高(OR 2.23,95%CI 1.14-4.38,P = .025),且每增加一天抗生素使用 odds 升高(OR 1.08,95%CI 1.03-1.13,P = .002)。
临床怎么用
- 作者认为这些数据提示医院可通过强有力的感染预防控制实践和抗生素管理项目干预,以预防住院患者定植。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The spread of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) represents a significant global public health threat. We identified putative risk factors for ESCrE and CRE colonization among patients in 1 urban and 3 rural hospitals in Kenya. METHODS: During a January 2019 and March 2020 cross-sectional study, stool samples were collected from randomized inpatients and tested for ESCrE and CRE. The Vitek2 instrument was used for isolate confirmation and antibiotic susceptibility testing, and least absolute shrinkage and selection operator (LASSO) regression models were used to identify colonization risk factors while varying antibiotic use measures. RESULTS: Most (76%) of the 840 enrolled participants received ≥1 antibiotic in the 14 days preceding their enrollment, primarily ceftriaxone (46%), metronidazole (28%), or benzylpenicillin-gentamycin (23%). For LASSO models that included ceftriaxone administration, ESCrE colonization odds were higher among patients hospitalized for ≥3 days (odds ratio, 2.32 [95% confidence interval, 1.6-3.37]; P < .001), intubated patients (1.73 [1.03-2.91]; P = .009), and persons living with human immunodeficiency virus (1.70 [1.03-2.8]; P = .029). CRE colonization odds were higher among patients receiving ceftriaxone (odds ratio, 2.23 [95% confidence interval, 1.14-4.38]; P = .025) and for every additional day of antibiotic use (1.08 [1.03-1.13]; P = .002). CONCLUSIONS: While CRE colonization was strongly associated with ceftriaxone use and duration of antibiotic use, the odds of ESCrE colonization increased with exposure to the hospital setting and invasive medical devices, which may reflect nosocomial transmission. These data suggest several areas where hospitals can intervene to prevent colonization among hospitalized patients, both through robust infection prevention and control practices and antibiotic stewardship programs.
引用
- Omulo S, Ita T, Mugoh R, et al. Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clin Infect Dis. 2023. PMID: 37406042. doi:10.1093/cid/ciad258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。